Related Experiment Video

Updated: Oct 19, 2025

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

1.1K

A Case Series of Extrapulmonary Mycobacterium in Liver Transplant Recipients

Kevin Lamm1, Carl Jacobs2, Mark W Russo1

  • 1Division of Hepatology, Department of Medicine, Carolinas Medical Center, Charlotte, NC.

ACG Case Reports Journal
|September 22, 2021
PubMed

Insights

Liver transplant recipients face higher infection risks due to immunosuppression. Prompt diagnosis and tailored treatment of Mycobacterium infections are crucial for survival and preserving liver allograft function.

Area of Science:

  • * Immunology and Infectious Diseases
  • * Hepatology and Transplant Medicine

Background:

  • * Liver transplant recipients require immunosuppression, increasing susceptibility to infections.
  • * Mycobacterium species pose a significant threat, elevating morbidity and mortality rates.

Observation:

  • * Opportunistic infections necessitate prompt recognition and diagnosis for favorable outcomes.
  • * Periods of intensified immunosuppression require careful management.
  • * Balancing immunosuppressive therapies with hepatotoxic medications needs further study.

Findings:

  • * Mycobacterium infections significantly impact liver transplant patient outcomes.
  • * Individualized treatment strategies are essential for managing immunosuppression and hepatotoxic drugs.

Implications:

  • * Early detection and management of infections are vital for liver transplant success.
  • * Personalized immunosuppressive therapy is key to preventing complications and preserving graft function.
  • * Further research is needed on optimizing immunosuppression in liver transplant patients on hepatotoxic medications.

More Related Videos

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

19.1K
Intradermal Inoculation of Mycobacterium avium in the Mouse Ear09:20

Intradermal Inoculation of Mycobacterium avium in the Mouse Ear

Published on: July 3, 2025

701

Related Concept Videos

Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
527
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
419
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
674
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
236
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
269